Teva Pharmaceutical: 3 Numbers That Explain This Generic-Drug Turnaround
Key PointsForecasts call for Teva's branded drug portfolio to bring it $3.7 billion in revenue next year.
Key PointsForecasts call for Teva's branded drug portfolio to bring it $3.7 billion in revenue next year.